Conference item : Abstract
A randomized, phase 3, double-blind trial examining methotrexate and etanercept as monotherapy or in combinstion for treating psoriatic arthritis: A comparison of the composite measures used to evaluate disease activity
- Publication status:
- Published
- Peer review status:
- Peer reviewed
Actions
Access Document
- Files:
-
-
(Preview, Accepted manuscript, pdf, 326.2KB, Terms of use)
-
- Publisher copy:
- 10.1136/annrheumdis-2019-eular.783
Authors
- Publisher:
- BMJ Publishing Group
- Host title:
- Annals of the Rheumatic Diseases
- Journal:
- ANNALS OF THE RHEUMATIC DISEASES More from this journal
- Volume:
- 78
- Issue:
- S2
- Pages:
- 129
- Publication date:
- 2019-05-27
- DOI:
- EISSN:
-
1468-2060
- ISSN:
-
0003-4967
- Subtype:
-
Abstract
- Pubs id:
-
pubs:1031821
- UUID:
-
uuid:f591932e-8eb8-4d4d-abff-9830177c569f
- Local pid:
-
pubs:1031821
- Source identifiers:
-
1031821
- Deposit date:
-
2019-07-29
- ARK identifier:
Terms of use
- Copyright holder:
- Mease et al
- Copyright date:
- 2019
- Notes:
- © Author(s) (or their employer(s)) 2019. This is the accepted manuscript version of the article. The final version is available online from BMJ Publishing Group at: 10.1136/annrheumdis-2019-eular.783
If you are the owner of this record, you can report an update to it here: Report update to this record